"Accurate dosing in botulinum toxin injections is extremely important! An injector is only as good as all the overall conditions.
We always think that we apply the planned dose per injection point, don't we? To my knowledge, no-one did really look at one aspect in toxin injections: the pre-clinical accuracy: we did measure if the estimated dose was always in the syringe and did find out that there was a huge variation of almost up to 20% using standard injection syringes and standard needles!
Using the 3Dose™ syringe, this is over: we know that we do exactly and reproducibly always get 1 unit of toxin per click!"
Triple Aesthetics Award Winner "Issues to consider when injecting botulinum toxin are the use of an appropriate syringe and needle system that is easy to use, delivers accurate doses, is comfortable for the patient and reduces toxin wastage. With this in mind VLOW Medical has recently developed and launched a unique and innovative disposable Botulinum Toxin delivery device"
Anna Baker: "Many conventional syringes do not afford the clinician the necessary level of accuracy required to administer low, precise doses, which is imperative to treat the musculature of the lower face safely and effectively. Errors of dosing may occur to parallax reading, and difficulty in controlling small dose delivery. The 3Dose™ botulinum toxin syringe is one way to avoid these errors."
"The clinician is advised to maintain a current and accurate awareness of the anatomy of the lower face, an appreciation of the age-related changes, as well as advances in the off-label indications of BoNTA, to deliver safe and effective treatments. In addition, the use of facial aesthetic scales are a useful consultation tool to discuss expected degree(s) of improvement with the individual.
The clinician is able to enhance the accuracy of treatment outcome through utilising injection delivery systems, such as the 3Dose™ botulinum toxin syringe, which have been shown to enhance the precision of targeted product placement, and thus minimise the risk of complications when treating the lower face with BoNTA."